We then performed immunostaining for these human breast cancer samples and found that in the ER-positive group, BRCA1-positive tumors whose BRCA1 mRNA levels were equal to or higher than 1.5 expressed moderate to strong GATA3 protein. The gene discussed is GATA3; the disease is breast cancer.